SELLAS Life Sciences Group's market cap is currently ―. The company's EPS TTM is $-1.363; its P/E ratio is -1.00; SELLAS Life Sciences Group is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	$ 0.00
EBIT	$ -9.36M	$ -9.05M	$ -11.28M	$ -9.57M	$ -7.15M
EBITDA	-	$ -8.89M	$ -11.19M	$ -9.57M	$ -7.15M
Net Income Common Stockholders	$ -9.27M	$ -8.84M	$ -11.10M	$ -9.12M	$ -7.02M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 4.00M	$ 13.90M	$ 24.00M	$ 17.23M	$ 21.35M
Total Assets	$ 8.09M	$ 18.56M	$ 29.10M	$ 20.94M	$ 26.00M
Total Debt	$ 644.00K	$ 749.00K	$ 849.00K	$ 945.00K	$ 1.04M
Net Debt	$ -3.36M	$ -13.15M	$ -23.15M	$ -16.28M	$ -20.31M
Total Liabilities	$ 11.91M	$ 13.72M	$ 15.94M	$ 16.09M	$ 13.40M
Stockholders Equity	$ -3.83M	$ 4.88M	$ 13.17M	$ 4.85M	$ 12.60M
Cash Flow	-
Free Cash Flow	-	$ -7.53M	$ -12.13M	$ -5.10M	$ -5.75M
Operating Cash Flow	$ -6.90M	$ -7.53M	$ -12.13M	$ -5.10M	$ -5.75M
Investing Cash Flow	$ -3.00M	$ -2.50M	-	-	$ 0.00
Financing Cash Flow	$ 54.00K	$ -29.00K	$ 18.90M	$ 929.00K	$ 107.00K

Currency in USD

SELLAS Life Sciences Group Earnings and Revenue History

Income Statement >

SELLAS Life Sciences Group Debt to Assets

Balance Sheet >

SELLAS Life Sciences Group Cash Flow

Cash Flow >

SELLAS Life Sciences Group Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing